Intestinal Research

Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis: Ryo Karashima, Shintaro Sagami, Yoko Yamana, Masa Maeda, Aya Hojo, Yusuke Miyatani, Masaru Nakano, Takahisa Matsuda, Toshifumi Hibi, Taku Kobayashi; Received September 27, 2023 Accepted April 9, 2024; DOI: https://doi.org/10.5217/ir.2023.00135 [Epub ahead of print]; Full text PubReader ePub PDF

Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities: Kanishk Aggarwal, Bhupinder Singh, Abhishek Goel, Durgesh Kumar Agrawal, Sourav Bansal, Sai Gautham Kanagala, Fnu Anamika, Aachal Gupta, Rohit Jain; Received December 31, 2023 Accepted April 15, 2024; DOI: https://doi.org/10.5217/ir.2024.00001 [Epub ahead of print]; Full text PubReader ePub PDF

Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study: Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh; Received March 20, 2024 Accepted April 15, 2024; DOI: https://doi.org/10.5217/ir.2024.00044 [Epub ahead of print]; Full text PubReader ePub PDF

What to do when traditional rescue therapies fail in acute severe ulcerative colitis: Christopher F. D. Li Wai Suen, Matthew C. Choy, Peter De Cruz; Received January 7, 2024 Accepted March 22, 2024; DOI: https://doi.org/10.5217/ir.2024.00003 [Epub ahead of print]; Full text PubReader ePub PDF

Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study: Xinyu Liu, Qingfan Yang, Na Diao, Jian Tang, Zicheng Huang, Xiang Gao, Kang Chao; Received August 21, 2023 Accepted February 29, 2024; DOI: https://doi.org/10.5217/ir.2023.00106 [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

IBD
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies: Taku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, Tadakazu Hisamatsu, Fumihito Hirai, Joe Milata, Xingyuan Li, Nathan Morris, Vipin Arora, Tomoko Ishizuka, Koji Matsuo, Yoichi Satoi, Catherine Milch, Toshifumi Hibi; Intest Res. 2024;22(2):172-185. Published online April 25, 2024; DOI: https://doi.org/10.5217/ir.2023.00043; Full text PubReader ePub PDF Supplementary Material

The evolving understanding of histology as an endpoint in ulcerative colitis: Shintaro Akiyama, Yusuke Miyatani, David T. Rubin; Received September 13, 2023 Accepted January 24, 2023; DOI: https://doi.org/10.5217/ir.2023.00120 [Epub ahead of print]; Full text PubReader ePub PDF

Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study: Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng; Received July 4, 2023 Accepted December 22, 2023; DOI: https://doi.org/10.5217/ir.2023.00078 [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study: Katsuyoshi Matsuoka, Tomoyuki Inoue, Hiroaki Tsuchiya, Katsumasa Nagano, Toshiyuki Iwahori; Received June 21, 2023 Accepted November 6, 2023; DOI: https://doi.org/10.5217/ir.2023.00071 [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing: Rahiya Rehman, Muhammad Safwan Riaz, Dyadin Esharif, Phinnara Has, Michael Herzlinger, Jason Shapiro, Shova Subedi; Received August 1, 2023 Accepted December 6, 2023; DOI: https://doi.org/10.5217/ir.2023.00091 [Epub ahead of print]; Full text PubReader ePub PDF

IBD
Association of colonic metaplasia of goblet cells and endoscopic phenotypes of the J pouch in patients with ulcerative colitis: a retrospective pilot study: Shintaro Akiyama, Tsubasa Onoda, Shoko Moue, Noriaki Sakamoto, Taku Sakamoto, Hideo Suzuki, Tsuyoshi Enomoto, Daisuke Matsubara, Tatsuya Oda, Kiichiro Tsuchiya; Intest Res. 2024;22(1):92-103. Published online January 29, 2024; DOI: https://doi.org/10.5217/ir.2023.00105
Web of Science 1 Crossref 1; Full text PubReader ePub PDF Supplementary Material

Sarcopenia is common in ulcerative colitis and correlates with disease activity: Pardhu B Neelam, Rimesh Pal, Pankaj Gupta, Anupam K Singh, Jimil Shah, Harshal S Mandavdhare, Harjeet Singh, Aravind Sekar, Sanjay K Bhadada, Usha Dutta, Vishal Sharma; Intest Res. 2024;22(2):162-171. Published online January 22, 2024; DOI: https://doi.org/10.5217/ir.2023.00090
Web of Science 1 Crossref 1; Full text PubReader ePub PDF Supplementary Material

Helminths in alternative therapeutics of inflammatory bowel disease: Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal; Received May 25, 2023 Accepted November 1, 2023; DOI: https://doi.org/10.5217/ir.2023.00059 [Epub ahead of print]; Full text PubReader ePub PDF

IBD
Precision medicine in inflammatory bowel diseases: Ashwin N. Ananthakrishnan; Intest Res. 2024;22(1):8-14. Published online November 9, 2023; DOI: https://doi.org/10.5217/ir.2023.00087
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study: Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park; Received June 3, 2023 Accepted September 14, 2023; DOI: https://doi.org/10.5217/ir.2023.00062 [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Search